Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Psychiatry].

J M Aubry1, A Delini-Stula, N Gervasoni

  • 1Service de psychiatrie adulte, HUG, Genève. jean-michel.aubry@hcuge.ch

Revue Medicale Suisse
|March 16, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Non-Response to Antidepressants: Risk Factors and Therapeutic Possibilities.

Pharmacopsychiatry·2026
Same author

Baseline clinical profile of patients with obstructive hypertrophic cardiomyopathy in the Italian Mavacamten early access program.

International journal of cardiology·2026
Same author

Precision medicine strategy in pancreatic ductal adenocarcinoma.

ESMO open·2025
Same author

Applicability and performance of heart failure prognostic scores in dilated cardiomyopathy: the real-world experience of an Italian referral center for cardiomyopathies.

International journal of cardiology·2023
Same author

Safety and tolerance of combination of monoamine oxidase inhibitors and direct dopamine agonists in adults and older adults with highly resistant depression.

L'Encephale·2023
Same author

Impact of the first wave of the COVID-19 pandemic on French Health students.

L'Encephale·2022
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
See all related articles

Duloxetine, a novel antidepressant, effectively treats depression and neuropathic pain by inhibiting noradrenaline and serotonin reuptake. This review also covers major studies on depression and schizophrenia treatments, plus current topics in bipolar disorder.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Psychiatry

Context:

  • Introduction of duloxetine (Cymbalta) in Switzerland.
  • Clinical evidence for duloxetine's efficacy in depression and neuropathic pain.
  • Review of major National Institute of Mental Health (NIMH) studies: STAR-D and CATIE.

Purpose:

  • To introduce duloxetine and its therapeutic applications.
  • To review key findings from the STAR-D and CATIE studies.
  • To discuss current issues in psychiatric treatment, including bipolar depression and childhood bipolar disorder.

Summary:

  • Duloxetine, a serotonin-noradrenaline reuptake inhibitor (SNRI), demonstrates efficacy and good tolerability for depression and neuropathic pain.
  • The STAR-D study provides insights into depression treatment strategies.

Related Experiment Videos

  • The CATIE study evaluates antipsychotic treatments for schizophrenia.

    • Impact:

    • Highlights duloxetine as a treatment option for specific conditions.
    • Informs clinical practice regarding depression and schizophrenia management.
    • Addresses emerging questions in the field of bipolar disorders.